{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:27Z","timestamp":1793727747225,"version":"4.6.1"},"reference-count":183,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006081","name":"Lounais-Suomen Sy\u00f6p\u00e4yhdistys","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009420","name":"Varsinais-Suomen Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["13336"],"award-info":[{"award-number":["13336"]}],"id":[{"id":"10.13039\/501100009420","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Skin cancers are the most common types of cancer worldwide, and their incidence is increasing. Melanoma, basal cell carcinoma (BCC), and cutaneous squamous cell carcinoma (cSCC) are the three major types of skin cancer. Melanoma originates from melanocytes, whereas BCC and cSCC originate from epidermal keratinocytes and are therefore called keratinocyte carcinomas. Chronic exposure to ultraviolet radiation (UVR) is a common risk factor for skin cancers, but they differ with respect to oncogenic mutational profiles and alterations in cellular signaling pathways. cSCC is the most common metastatic skin cancer, and it is associated with poor prognosis in the advanced stage. An important early event in cSCC development is mutation of the TP53 gene and inactivation of the tumor suppressor function of the tumor protein 53 gene (TP53) in epidermal keratinocytes, which then leads to accumulation of additional oncogenic mutations. Additional genomic and proteomic alterations are required for the progression of premalignant lesion, actinic keratosis, to invasive and metastatic cSCC. Recently, the role of p53 in the invasion of cSCC has also been elucidated. In this review, the role of p53 in the progression of cSCC and as potential new therapeutic target for cSCC will be discussed.<\/jats:p>","DOI":"10.3390\/cancers13184507","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T10:24:25Z","timestamp":1631010265000},"page":"4507","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5078-3029","authenticated-orcid":false,"given":"Minna","family":"Piipponen","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Turku and Turku University Hospital, H\u00e4meentie 11 TE6, FI-20520 Turku, Finland"},{"name":"FICAN West Cancer Centre Research Laboratory, University of Turku and Turku University Hospital, Kiinamyllynkatu 10, FI-20520 Turku, Finland"},{"name":"Center for Molecular Medicine, Department of Medicine Solna, Dermatology and Venereology Division, Karolinska Institute, 17176 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2934-0645","authenticated-orcid":false,"given":"Pilvi","family":"Riihil\u00e4","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Turku and Turku University Hospital, H\u00e4meentie 11 TE6, FI-20520 Turku, Finland"},{"name":"FICAN West Cancer Centre Research Laboratory, University of Turku and Turku University Hospital, Kiinamyllynkatu 10, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6743-6736","authenticated-orcid":false,"given":"Liisa","family":"Nissinen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Turku and Turku University Hospital, H\u00e4meentie 11 TE6, FI-20520 Turku, Finland"},{"name":"FICAN West Cancer Centre Research Laboratory, University of Turku and Turku University Hospital, Kiinamyllynkatu 10, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-9368","authenticated-orcid":false,"given":"Veli-Matti","family":"K\u00e4h\u00e4ri","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Turku and Turku University Hospital, H\u00e4meentie 11 TE6, FI-20520 Turku, Finland"},{"name":"FICAN West Cancer Centre Research Laboratory, University of Turku and Turku University Hospital, Kiinamyllynkatu 10, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1708701","article-title":"Update on keratinocyte carcinomas","volume":"379","author":"Nehal","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamadermatol.2018.4219","article-title":"Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England","volume":"155","author":"Venables","year":"2019","journal-title":"JAMA Derm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013\u201315: A cohort study","volume":"181","author":"Venables","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence Estimate of Nonmelanoma SkinCancer (Keratinocyte Carcinomas) in the U.S. Population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Derm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: An epidemiological review","volume":"177","author":"Green","year":"2017","journal-title":"Br. J. Derm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2017.02.015","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: A population-based study in Olmsted County, Minnesota, 2000 to 2010","volume":"92","author":"Muzic","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"adv00266","DOI":"10.2340\/00015555-3628","article-title":"Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: A cohort study","volume":"100","author":"Knuutila","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40257-016-0207-3","article-title":"Cutaneous squamous cell carcinoma: A review of high-risk and metastatic disease","volume":"17","author":"Burton","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bjoms.2014.01.015","article-title":"Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma","volume":"52","author":"Gurney","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaad.2017.11.026","article-title":"All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis","volume":"78","author":"Wehner","year":"2018","journal-title":"J. Am. Acad. Derm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cncr.30601","article-title":"A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck","volume":"123","author":"Manyam","year":"2017","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J. Am. Acad. Derm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: A 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Derm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jso.24707","article-title":"Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: Do we need to adjust our thinking on this rare but potentially fatal event?","volume":"116","author":"Nelson","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.wjorl.2016.05.004","article-title":"High risk cutaneous squamous cell carcinoma of the head and neck","volume":"2","author":"Kang","year":"2016","journal-title":"World J. Otorhinolaryngol. Head Neck Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s004280050327","article-title":"Sun-exposure- and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer","volume":"434","author":"Liang","year":"1999","journal-title":"Virchows Arch."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1158\/1055-9965.2006.13.12","article-title":"UV dose determines key characteristics of nonmelanoma skin cancer","volume":"13","author":"Ramos","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamadermatol.2014.762","article-title":"Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978\u20132012: Empirical relationships","volume":"150","author":"Xiang","year":"2014","journal-title":"JAMA Derm."},{"key":"ref_19","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Sigurgeirsson","year":"2000","journal-title":"Br. J. Derm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5306\/wjco.v4.i4.85","article-title":"Squamous cell carcinoma of the skin: Emerging need for novel biomarkers","volume":"4","author":"Kivisaari","year":"2013","journal-title":"World J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: A 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamadermatol.2013.6249","article-title":"Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia","volume":"150","author":"Velez","year":"2014","journal-title":"JAMA Derm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaad.2014.10.028","article-title":"Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: A Rochester Epidemiology Project population-based study in Minnesota","volume":"72","author":"Brewer","year":"2015","journal-title":"J. Am. Acad. Derm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3389\/fmicb.2018.01806","article-title":"The role of human papillomaviruses and polyomaviruses in BRAF-Inhibitor induced cutaneous squamous cell carcinoma and benign squamoproliferative lesions","volume":"9","author":"Purdie","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10552-020-01319-8","article-title":"The association between smoking and risk of skin cancer: A meta-analysis of cohort studies","volume":"8","author":"Arafa","year":"2020","journal-title":"Cancer Causes Control."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cll.2017.06.003","article-title":"Cutaneous squamous cell carcinoma","volume":"37","author":"Parekh","year":"2017","journal-title":"Clin. Lab. Med."},{"key":"ref_28","first-page":"e210372","article-title":"Ten-year follow-up of persons with sun-damaged skin associated with subsequent development of cutaneous squamous cell carcinoma","volume":"24","author":"Madani","year":"2021","journal-title":"JAMA Derm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/jamadermatol.2015.1702","article-title":"Outcomes of patients with multiple cutaneous squamous cell carcinomas: A 10-year single-institution cohort study","volume":"151","author":"Levine","year":"2015","journal-title":"JAMA Derm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: A systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Derm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2017.07.031","article-title":"A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management","volume":"78","author":"Baum","year":"2018","journal-title":"J. Am. Acad. Derm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am. Acad. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamadermatol.2017.6428","article-title":"Validating 4 staging systems for cutaneous squamous cell carcinoma using population-based data: A nested case-control study","volume":"154","author":"Roscher","year":"2018","journal-title":"JAMA Derm."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zeng, S., Fu, L., Zhou, P., and Ling, H. (2020). Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239586"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.0007-0963.2001.04615.x","article-title":"Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma","volume":"146","author":"Motley","year":"2002","journal-title":"Br. J. Derm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/jid.2014.154","article-title":"NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin. Cancer. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational landscape of aggressive cutaneous squamous cell carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"eaas9668","DOI":"10.1126\/scitranslmed.aas9668","article-title":"APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa","volume":"10","author":"Cho","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jid.2019.01.008","article-title":"Mutational patterns in metastatic cutaneous squamous cell carcinoma","volume":"139","author":"Mueller","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/2159-8290.CD-11-0028","article-title":"Temporal dissection of tumorigenesis in primary cancers","volume":"1","author":"Durinck","year":"2011","journal-title":"Cancer Discov."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/1523-1747.ep12475717","article-title":"p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin","volume":"100","author":"Campbell","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/372773a0","article-title":"Sunburn and p53 in the onset of skin cancer","volume":"372","author":"Ziegler","year":"1994","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/1523-1747.ep12395643","article-title":"Aberrations of the Tumor Suppressor P53 Gene and P53 Protein in Solar Keratosis in Human Skin","volume":"103","author":"Taguchi","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/cncr.30459","article-title":"Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors","volume":"123","author":"Yilmaz","year":"2017","journal-title":"Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.0022-202X.2004.22501.x","article-title":"p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma","volume":"122","author":"Brown","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies","volume":"122","author":"Tarasen","year":"2016","journal-title":"Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","article-title":"High burden and pervasive positive selection of somatic mutations in normal human skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41525-021-00226-4","article-title":"The landscape of driver mutations in cutaneous squamous cell carcinoma","volume":"6","author":"Chang","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lobl, M.B., Clarey, D., Schmidt, C., Wichman, C., and Wysong, A. (2021). Analysis of mutations in cutaneous squamous cell carcinoma reveals novel genes and mutations associated with patient-specific characteristics and metastasis: A systematic review. Arch. Dermatol. Res.","DOI":"10.1007\/s00403-021-02213-2"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/ncomms12493","article-title":"Inactivation of TGF\u03b2 receptors in stem cells drives cutaneous squamous cell carcinoma","volume":"7","author":"Cammareri","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"17761","DOI":"10.1073\/pnas.1114669108","article-title":"Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1101\/gad.1484707","article-title":"Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1\/2 and MRCKalpha kinases","volume":"21","author":"Lefort","year":"2007","journal-title":"Genes Dev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jid.2020.05.116","article-title":"Whole-exome and transcriptome analysis of uv-exposed epidermis and carcinoma in situ reveals early drivers of carcinogenesis","volume":"141","author":"Zheng","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1073\/pnas.87.23.9178","article-title":"v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid","volume":"87","author":"Leder","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"19361","DOI":"10.3390\/ijms141019361","article-title":"EGFR-ras-raf signaling in epidermal stem cells: Roles in hair follicle development, regeneration, tissue remodeling and epidermal cancers","volume":"14","author":"Doma","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1093\/emboj\/18.17.4657","article-title":"Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis","volume":"18","author":"Sano","year":"1999","journal-title":"EMBO J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.onc.1210726","article-title":"Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis","volume":"27","author":"Chan","year":"2008","journal-title":"Oncogene"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/carcin\/bgn061","article-title":"Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis","volume":"29","author":"Kataoka","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.05.016","article-title":"Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases","volume":"50","author":"Sano","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI200421032","article-title":"Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis","volume":"114","author":"Chan","year":"2004","journal-title":"J. Clin. Invest."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/onc.2008.453","article-title":"Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis","volume":"28","author":"Kim","year":"2009","journal-title":"Oncogene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1158\/0008-5472.CAN-04-4359","article-title":"Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation","volume":"65","author":"Sano","year":"2005","journal-title":"Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1126\/science.aam7304","article-title":"The cancer epigenome: Concepts, challenges, and therapeutic opportunities","volume":"355","author":"Dawson","year":"2017","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1365-2133.2006.07487.x","article-title":"Epigenetic abnormalities in cutaneous squamous cell carcinomas: Frequent inactivation of the RB1\/p16 and p53 pathways","volume":"155","author":"Murao","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Meier, K., Drexler, S.K., Eberle, F.C., Lefort, K., and Yazdi, A.S. (2016). Silencing of ASC in cutaneous squamous cell carcinoma. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164742"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/01.MP.0000089779.35435.9D","article-title":"E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions","volume":"16","author":"Chiles","year":"2003","journal-title":"Mod. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13059-015-0644-y","article-title":"Age and sun exposure-related widespread genomic blocks of hypomethylation in nonmalignant skin","volume":"16","author":"Vandiver","year":"2015","journal-title":"Genome Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41467-018-03025-1","article-title":"Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin","volume":"9","author":"Bormann","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Tramutola, A., Falcucci, S., Brocco, U., Triani, F., Lanzillotta, C., Donati, M., Panetta, C., Luzi, F., Iavarone, F., and Vincenzoni, F. (2020). Protein oxidative damage in uv-related skin cancer and dysplastic lesions contributes to neoplastic promotion and progression. Cancers, 12.","DOI":"10.3390\/cancers12010110"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00441-016-2457-z","article-title":"New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma","volume":"365","author":"Nissinen","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1007\/s00018-020-03554-3","article-title":"Long non-coding RNAs in cutaneous biology and keratinocyte carcinomas","volume":"77","author":"Piipponen","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2020.05.039","article-title":"Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma","volume":"182","author":"Ji","year":"2020","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"636544","DOI":"10.3389\/fcell.2021.636544","article-title":"The tumor microenvironment in scc: Mechanisms and therapeutic opportunities","volume":"9","author":"Santos","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.matbio.2019.09.001","article-title":"H-Ras activation and fibroblast-induced TGF-\u03b2 signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma","volume":"87","author":"Rappu","year":"2020","journal-title":"Matrix Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"djv293","DOI":"10.1093\/jnci\/djv293","article-title":"Suppression of tgf\u03b2 and angiogenesis by type vii collagen in cutaneous scc","volume":"108","author":"Martins","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/exd.12913","article-title":"Collagens XV and XVIII show different expression and localisation in cutaneous squamous cell carcinoma: Type XV appears in tumor stroma, while XVIII becomes upregulated in tumor cells and lost from microvessels","volume":"25","author":"Karppinen","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"P53, the Cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jmcb\/mjz060","article-title":"P53 modifications: Exquisite decorations of the powerful guardian","volume":"11","author":"Liu","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/sj.neo.7900061","article-title":"Relationship of P53 mutations to epidermal cell proliferation and apoptosis in human uv-induced skin carcinogenesis","volume":"1","author":"Einspahr","year":"1999","journal-title":"Neoplasia"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00403-020-02104-y","article-title":"P53 staining index and zonal staining patterns in actinic keratoses","volume":"313","author":"Javor","year":"2021","journal-title":"Arch. Dermatol. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jid.2017.07.844","article-title":"Subclonal evolution of cancer-related gene mutations in p53 immunopositive patches in human skin","volume":"138","author":"Albibas","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"eaaw0726","DOI":"10.1126\/science.aaw0726","article-title":"RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues","volume":"364","author":"Yizhak","year":"2019","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/2159-8290.CD-20-1092","article-title":"Selection of oncogenic mutant clones in normal human skin varies with body site","volume":"11","author":"Fowler","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"eabd7703","DOI":"10.1126\/sciadv.abd7703","article-title":"Ultradeep sequencing differentiates patterns of skin clonal mutations associated with sun-exposure status and skin cancer burden","volume":"7","author":"Wei","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14025","DOI":"10.1073\/pnas.93.24.14025","article-title":"Frequent clones of p53-mutated keratinocytes in normal human skin","volume":"93","author":"Jonason","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/jid.2010.302","article-title":"Sun-Induced nonsynonymous p53 mutations are extensively accumulated and tolerated in normal appearing human skin","volume":"131","author":"Stranneheim","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1158\/0008-5472.CAN-04-4537","article-title":"Patches of Mutant P53-immunoreactive epidermal cells induced by chronic uvb irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice","volume":"65","author":"Kramata","year":"2005","journal-title":"Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.stem.2018.08.017","article-title":"Epidermal tissue adapts to restrain progenitors carrying clonal p53 mutations","volume":"23","author":"Murai","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1038\/sj.onc.1208863","article-title":"Fate of UVB-Induced P53 mutations in SKH-Hr1 mouse skin after discontinuation of irradiation: Relationship to skin cancer development","volume":"24","author":"Melnikova","year":"2005","journal-title":"Oncogene"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"a028308","DOI":"10.1101\/cshperspect.a028308","article-title":"Structural evolution and dynamics of the P53 proteins","volume":"7","author":"Chillemi","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"a015248","DOI":"10.1101\/cshperspect.a015248","article-title":"P53\/P63\/P73 in the epidermis in health and disease","volume":"4","author":"Botchkarev","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"69549","DOI":"10.18632\/oncotarget.11774","article-title":"The Dominant-negative interplay between P53, P63 and P73: A family affair","volume":"7","author":"Billant","year":"2016","journal-title":"Oncotarget"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1158\/0008-5472.CAN-19-1892","article-title":"TAp63-Regulated mirnas suppress cutaneous squamous cell carcinoma through inhibition of a network of cell-cycle genes","volume":"80","author":"Davis","year":"2020","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2009.11.026","article-title":"Mutant P53 drives invasion by promoting integrin recycling","volume":"139","author":"Muller","year":"2009","journal-title":"Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/1878-0261.12473","article-title":"\u0394Np63 in squamous cell carcinoma: Defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment","volume":"13","author":"Gatti","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jid.2019.01.020","article-title":"Epigenetic Regulation of IASPP-P63 Feedback loop in cutaneous squamous cell carcinoma","volume":"139","author":"Robinson","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.18632\/oncotarget.382","article-title":"Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome","volume":"12","author":"Neilsen","year":"2011","journal-title":"Oncotarget."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1038\/onc.2017.66","article-title":"Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer","volume":"31","author":"Shakya","year":"2017","journal-title":"Oncogene."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cbio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Jacobsen, A., Sinha, R., and Larsson, E. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal., 269.","DOI":"10.1126\/scisignal.2004088"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"a026054","DOI":"10.1101\/cshperspect.a026054","article-title":"Transcriptional regulation by wild-type and cancer-related mutant forms of P53","volume":"7","author":"Pfister","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/cdd.2017.185","article-title":"Mutant P53 Partners in crime","volume":"25","author":"Kim","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jmb.2017.03.030","article-title":"Mutant P53 in cancer: Accumulation, gain-of-function, and therapy","volume":"429","author":"Yue","year":"2017","journal-title":"J. Mol. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"13234","DOI":"10.1074\/jbc.RA118.003387","article-title":"Mutant P53 regulates enhancer-associated h3k4 monomethylation through interactions with the methyltransferase MLL4","volume":"293","author":"Rahnamoun","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1101\/gad.263202.115","article-title":"Mutant P53 cooperates with the swi\/snf chromatin remodeling complex to regulate VEGFR2 in breast cancer cells","volume":"29","author":"Pfister","year":"2015","journal-title":"Genes Dev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature15251","article-title":"Gain-of-Function P53 mutants co-opt chromatin pathways to drive cancer growth","volume":"525","author":"Zhu","year":"2015","journal-title":"Nature"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1038\/ncomms12601","article-title":"Cross-Species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates","volume":"7","author":"Chitsazzadeh","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/sj.onc.1207396","article-title":"Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes","volume":"23","author":"Willis","year":"2004","journal-title":"Oncogene"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ncb1571","article-title":"P53 Gain-of-Function cancer mutants induce genetic instability by inactivating ATM","volume":"9","author":"Song","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/jcb.25592","article-title":"TP53 Mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response","volume":"117","author":"Zhou","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41388-017-0032-z","article-title":"Gain-of-Function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1","volume":"37","author":"Tanaka","year":"2018","journal-title":"Oncogene"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cell.2009.01.039","article-title":"A Mutant-P53\/Smad complex opposes p63 to empower TGF-\u03b2-induced metastasis","volume":"137","author":"Adorno","year":"2009","journal-title":"Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/onc.2014.359","article-title":"Functional interplay between MDM2, P63\/P73 and mutant P53","volume":"34","author":"Stindt","year":"2015","journal-title":"Oncogene"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.4770","article-title":"Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H)","volume":"240","author":"Li","year":"2016","journal-title":"J. Pathol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1038\/onc.2011.441","article-title":"Myc, Aurora Kinase A, and Mutant P53(R172H) Co-operate in a mouse model of metastatic skin carcinoma","volume":"31","author":"Torchia","year":"2012","journal-title":"Oncogene"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1172\/JCI31721","article-title":"An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations","volume":"117","author":"Caulin","year":"2007","journal-title":"J. Clin. Invest."},{"key":"ref_120","first-page":"1091","article-title":"The Evolution of tp53 mutations: From loss-of-function to separation-of-function mutants","volume":"4","author":"Miller","year":"2016","journal-title":"J. Cancer Biol. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"64910","DOI":"10.18632\/oncotarget.11912","article-title":"Immunohistochemical correlates of tp53 somatic mutations in cancer","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(93)90461-X","article-title":"Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors","volume":"74","author":"Kemp","year":"1993","journal-title":"Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1523-1747.1998.00090.x","article-title":"Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation","volume":"110","author":"Li","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"ref_124","first-page":"2070","article-title":"Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice","volume":"55","author":"Li","year":"1995","journal-title":"Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1158\/0008-5472.CAN-07-3049","article-title":"Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and trp53 tumor suppressors","volume":"68","author":"Santos","year":"2008","journal-title":"Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/onc.2013.585","article-title":"Loss of Epithelial P53 and Av Integrin cooperate through akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment","volume":"34","author":"Savar","year":"2015","journal-title":"Oncogene"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Vieler, M., and Sanyal, S. (2018). P53 Isoforms and their implications in cancer. Cancers, 10.","DOI":"10.3390\/cancers10090288"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"E3287","DOI":"10.1073\/pnas.1321640111","article-title":"P53\u03a8 Is a Transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state","volume":"111","author":"Senturk","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Shirole, N.H., Pal, D., Kastenhuber, E.R., Senturk, S., Boroda, J., Pisterzi, P., Miller, M., Munoz, G., Anderluh, M., and Ladanyi, M. (2016). TP53 Exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions. Elife, 5.","DOI":"10.7554\/eLife.17929"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/path.5328","article-title":"Intratumour heterogeneity of p53 expression; causes and consequences","volume":"249","author":"Xue","year":"2019","journal-title":"J. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"33952","DOI":"10.1038\/srep33952","article-title":"Thickness of actinic keratosis does not predict dysplasia severity or p53 Expression","volume":"6","author":"Heerfordt","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"20902","DOI":"10.18632\/oncotarget.7897","article-title":"Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53","volume":"7","author":"Page","year":"2016","journal-title":"Oncotarget"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"614230","DOI":"10.3389\/fonc.2020.614230","article-title":"Amplifying tumor-stroma communication: An emerging oncogenic function of mutant p53","volume":"10","author":"Capaci","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/exd.14183","article-title":"Matrix metalloproteinases in keratinocyte carcinomas","volume":"30","author":"Nissinen","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.onc.1205198","article-title":"Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells","volume":"21","author":"Seth","year":"2002","journal-title":"Oncogene"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1006\/mthe.2002.0606","article-title":"Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3","volume":"5","author":"Ahonen","year":"2002","journal-title":"Mol. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-42059-2_1","article-title":"Non-Coding RNAs: Classification, biology and functioning","volume":"937","author":"Hombach","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding rnas and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tibs.2018.09.007","article-title":"TsRNAs: The swiss army knife for translational regulation","volume":"44","author":"Shi","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding rnas in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Chen, S., Thorne, R.F., Zhang, X.D., Wu, M., and Liu, L. (2020). Non-Coding RNAs, guardians of the p53 galaxy. Semin. Cancer Biol.","DOI":"10.1016\/j.semcancer.2020.09.002"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.7150\/ijbs.33218","article-title":"Emerging roles of p53 related lncrnas in cancer progression: A systematic review","volume":"15","author":"Lin","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Di Agostino, S. (2020). The Impact of Mutant P53 in the Non-Coding RNA world. Biomolecules, 10.","DOI":"10.3390\/biom10030472"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.15252\/embr.201643370","article-title":"The mutant p53-id4 complex controls VEGFA isoforms by recruiting lncrna MALAT1","volume":"18","author":"Pruszko","year":"2017","journal-title":"EMBO Rep."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Garofoli, M., Volpicella, M., Guida, M., Porcelli, L., and Azzariti, A. (2020). The Role of Non-Coding RNAs as Prognostic Factor, Predictor of Drug Response or Resistance and pharmacological targets, in the cutaneous squamous cell carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12092552"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.omtn.2020.01.022","article-title":"Tumor-suppressive microrna-216b binds to tpx2, activating the p53 signaling in human cutaneous squamous cell carcinoma","volume":"20","author":"Feng","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Matson, D.R., Denu, R.A., Zasadil, L.M., Burkard, M.E., Weaver, B.A., Flynn, C., and Stukenberg, P.T. (2021). High nuclear tpx2 expression correlates with tp53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07893-7"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1002\/hsr2.205","article-title":"Dysregulation of tissue and serum micrornas in organ transplant recipients with cutaneous squamous cell carcinomas","volume":"3","author":"Geusau","year":"2020","journal-title":"Heal. Sci. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Sancha, N., Corchado-Cobos, R., P\u00e9rez-Losada, J., and Ca\u00f1ueto, J. (2019). MicroRNA dysregulation in cutaneous squamous cell carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092181"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ajpath.2019.10.019","article-title":"p53-regulated long noncoding RNA PRECSIT promotes progression of cutaneous squamous cell carcinoma via STAT3 signaling","volume":"190","author":"Piipponen","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/0008-5472.CAN-19-0905","article-title":"Mapping and making sense of noncoding mutations in the genome","volume":"79","author":"Yang","year":"2019","journal-title":"Cancer Res."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Gao, P., and Wei, G.-H. (2017). Genomic insight into the role of lncrna in cancer susceptibility. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061239"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA Modifications in Cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J. Am. Acad Derm."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0190-9622(92)70074-P","article-title":"Squamous cell carcinoma of the skin (excluding lip and oral mucosa)","volume":"26","author":"Johnson","year":"1992","journal-title":"J. Am. Acad. Derm."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2020.01.008","article-title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment","volume":"128","author":"Stratigos","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_158","first-page":"651","article-title":"In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: Clinical characteristics, management, and outcome in a series of 21 patients","volume":"30","author":"Carucci","year":"2004","journal-title":"Derm. Surg."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"adv00143","DOI":"10.2340\/00015555-3498","article-title":"Update of the management of cutaneous squamous-cell carcinoma","volume":"100","author":"Maubec","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejca.2018.01.075","article-title":"Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns\u2014Results of a non-interventional study of the DeCOG","volume":"96","author":"Hillen","year":"2018","journal-title":"Eur. J. Cancer."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"299e303","DOI":"10.1001\/jamadermatol.2016.5118","article-title":"Expression of programmed cell death ligand in cutaneous squamous cell carcinoma and treatment of locally advanced disease with pembrolizumab","volume":"153","author":"Stevenson","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cup.12728","article-title":"PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis","volume":"43","author":"Slater","year":"2016","journal-title":"J. Cutan. Pathol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.03054","article-title":"Pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase II trial (KEYNOTE-629)","volume":"38","author":"Grob","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1038\/sj.onc.1205704","article-title":"Novel gain of function activity of p53 mutants: Activation of the dUTPase gene expression leading to resistance to 5-fluorouracil","volume":"21","author":"Pugacheva","year":"2002","journal-title":"Oncogene"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"692","DOI":"10.21037\/tcr.2016.11.76","article-title":"Regulation of cytotoxic T-cell responses by p53 in cancer","volume":"5","author":"Braun","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1261669","DOI":"10.1126\/science.1261669","article-title":"Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53","volume":"349","author":"Yoon","year":"2015","journal-title":"Science"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Agupitan, A.D., Neeson, P., Williams, S., Howitt, J., Haupt, S., and Haupt, Y. (2020). P53: A guardian of immunity becomes its saboteur through mutation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103452"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"102785","DOI":"10.1016\/j.dnarep.2020.102785","article-title":"Cancer type-dependent correlations between TP53 mutations and antitumor immunity","volume":"88","author":"Li","year":"2020","journal-title":"DNA Repair"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of p53: All mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ccell.2018.11.004","article-title":"BH3-mimetic drugs: Blazing the trail for new cancer medicines","volume":"34","author":"Merino","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Michel, M., Kaps, L., Maderer, A., Galle, P.R., and Moehler, M. (2021). The role of p53 dysfunction in colorectal cancer and its implication for therapy. Cancers, 13.","DOI":"10.3390\/cancers13102296"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"595187","DOI":"10.3389\/fonc.2020.595187","article-title":"Mutant p53 in cancer progression and targeted therapies","volume":"10","author":"Zhu","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Timofeev, O., and Stiewe, T. (2021). Rely on Each Other: Dna binding cooperativity shapes p53 functions in tumor suppression and cancer therapy. Cancers, 13.","DOI":"10.3390\/cancers13102422"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1172\/JCI32481","article-title":"CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice","volume":"117","author":"Tang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_176","unstructured":"(2021, May 19). Available online: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02999893."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ccr.2012.03.042","article-title":"Allele-specific p53 mutant reactivation","volume":"21","author":"Yu","year":"2012","journal-title":"Cancer Cell."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.cdd.4402301","article-title":"A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L\/TRAIL-induced apoptosis","volume":"15","author":"Weinmann","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_179","unstructured":"(2021, May 19). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02842125."},{"key":"ref_180","unstructured":"(2021, May 19). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03544723."},{"key":"ref_181","unstructured":"(2021, May 19). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00017173."},{"key":"ref_182","unstructured":"(2021, May 19). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00404339."},{"key":"ref_183","unstructured":"(2021, May 19). Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02432963."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4507\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:58:07Z","timestamp":1760165887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":183,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["cancers13184507"],"URL":"https:\/\/doi.org\/10.3390\/cancers13184507","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,7]]}}}